Home Cart 0 Sign in  

[ CAS No. 51135-73-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 51135-73-0
Chemical Structure| 51135-73-0
Structure of 51135-73-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 51135-73-0 ]

Related Doc. of [ 51135-73-0 ]

Alternatived Products of [ 51135-73-0 ]

Product Details of [ 51135-73-0 ]

CAS No. :51135-73-0 MDL No. :MFCD01631119
Formula : C7H9NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :KOMSQTMQKWSQDW-UHFFFAOYSA-N
M.W : 155.15 Pubchem ID :7009317
Synonyms :

Calculated chemistry of [ 51135-73-0 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.43
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 37.56
TPSA : 52.33 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.54 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.11
Log Po/w (XLOGP3) : 0.99
Log Po/w (WLOGP) : 1.16
Log Po/w (MLOGP) : 0.33
Log Po/w (SILICOS-IT) : 1.39
Consensus Log Po/w : 1.2

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.56
Solubility : 4.23 mg/ml ; 0.0273 mol/l
Class : Very soluble
Log S (Ali) : -1.68
Solubility : 3.26 mg/ml ; 0.021 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.09
Solubility : 1.26 mg/ml ; 0.00809 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.72

Safety of [ 51135-73-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 51135-73-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 51135-73-0 ]
  • Downstream synthetic route of [ 51135-73-0 ]

[ 51135-73-0 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 51135-73-0 ]
  • [ 42831-50-5 ]
YieldReaction ConditionsOperation in experiment
99.9% With sulfuric acid In o-tolyl acetic acid EXAMPLE 4
Preparation of 5-Methylisoxazole-4-Carboxylic Acid
A two-necked flask fitted with mechanical stirrer and a horizontal condenser for distillation was charged with 40.0 g of crude Ethyl-5-methylisoxazole-4-carboxylate and 44 g of 60percent sulfuric acid and the mixture was heated to 85° C. with continuous distillation of ethanol from the reaction product.
After four hours of heating at 85° C., TLC showed the complete disappearance of the upper spot of ester.
The mixture was allowed to cool in the refrigerator and the solid acid was filtered (16.5 g) Filtrate kept at room temperature for second crop.
Acid was crystallized in 60 mL 2percent acetic acid-Toluene to obtain about 99.9percent pure acid (9.5 g).
Mother liquor of the final crystallization was kept for second crop.
Crystallization was accomplished by:
The crude acid was taken in 2percent acetic acid-toluene mixture and heated for 30 minutes.
Brown oil was separated at the bottom of the flask.
The clear organic phase was neatly transferred and kept for crystallization.
60% With sulfuric acid In water at 20℃; for 20 h; Reflux Ethyl-5-methylisoxazole-4-carboxylate 7 g (0.045 mol) was heated under reflux in aqueous sulphuric acid (20 percent v/v, 30 ml) for 16 hr followed by cooling to room temperature with stirring for 4 h. The crystallized solid product was filtered and washed using toluene followed by water and dried. The product then was crystallized from ethanol to produce 3.5 g (60 percent) of 5-Methylisoxazole-4-carboxylic acid as a white solid, mp. 147-148 °C (reported mp. 144-147 °C).
Reference: [1] Patent: US2003/139606, 2003, A1,
[2] Letters in Drug Design and Discovery, 2016, vol. 13, # 9, p. 912 - 920
[3] Journal of Heterocyclic Chemistry, 1991, vol. 28, # 2, p. 453 - 457
[4] Yakugaku Zasshi, 1959, vol. 79, p. 836[5] Chem.Abstr., 1960, p. 1493
[6] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1988, p. 1875 - 1880
[7] Patent: WO2007/86076, 2007, A2, . Location in patent: Page/Page column 5; 7
[8] Asian Journal of Chemistry, 2010, vol. 22, # 2, p. 1503 - 1506
[9] Patent: EP257882, 1991, B1,
[10] Patent: US4892963, 1990, A,
[11] Patent: US4983619, 1991, A,
[12] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 23, p. 502
  • 2
  • [ 3788-94-1 ]
  • [ 51135-73-0 ]
YieldReaction ConditionsOperation in experiment
79% With hydroxylamine In methanol; water at -5 - 30℃; for 2.5 h; Heating / reflux Ethyl-5-methylisoxazole-4-carboxylate:Ethyl ethoxymethyleneacetoacetate, 110.00 g (0.59 mol) was taken in methanol (330 ml) and cooled to -5 0C and 50percent aqueous hydroxyl amine 39.03 g (0.59 mol on anhydrous basis) was added drop wise over a period of 1 hour at -5 to O0C. It was stirred for 30 minutes. The reaction mixture was allowed to attain temperature of 20 to 30 0C and then refluxed for 1 S hour. Solvent was removed under reduced pressure and the reaction mass was cooled to room temperature. n-Hexane (500 ml) was added and stirred for 30 minutes. Saturated sodium bicarbonate solution (100 ml) was added followed by water (400 ml) and stirred well. The organic layer was separated. The aqueous layer was re-extracted with n-hexane (2x200 ml). The combined organic layer was washed with water (2x250 ml). After removal of the solvent <n="8"/>72.5 g (79percent) of Ethyl-5-methylisoxazole-4-carboxylate was obtained as yellowish thick oil with 98.7 percent HPLC purity and having isomeric impurity less than 0.5 percent.
78% With hydroxylamine hydrochloride; sodium acetate In methanol; water at 0 - 20℃; Solution of hydroxylamine hydrochloride (4.1 g, 0.059 mol) and sodium acetate (4.84 g, 0.059 mol) in water (10 ml) was added dropwise to a solution of compound 3 (11 g, 0.059 mol) in methanol (25 ml) at 0 °C. The mixture was stirred during overnight at room temperature followed by extraction with EtOAc (3 x 50 ml), the combined EtOAc extract was washed by aqueous sodium bicarbonate solution to minimize the impurities and dried over Na2SO4. After that the solvent was removed to afford 7.16 g (78 percent) of Ethyl-5-methylisoxazole-4-carboxylate as yellow oil, which was used directly in the next step.
Reference: [1] Patent: WO2007/86076, 2007, A2, . Location in patent: Page/Page column 5-7
[2] Letters in Drug Design and Discovery, 2016, vol. 13, # 9, p. 912 - 920
[3] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1988, p. 1875 - 1880
[4] Asian Journal of Chemistry, 2010, vol. 22, # 2, p. 1503 - 1506
  • 3
  • [ 134653-70-6 ]
  • [ 20328-15-8 ]
  • [ 51135-73-0 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1991, vol. 28, # 2, p. 453 - 457
  • 4
  • [ 141-97-9 ]
  • [ 51135-73-0 ]
Reference: [1] Letters in Drug Design and Discovery, 2016, vol. 13, # 9, p. 912 - 920
  • 5
  • [ 33142-24-4 ]
  • [ 51135-73-0 ]
Reference: [1] Yakugaku Zasshi, 1959, vol. 79, p. 836[2] Chem.Abstr., 1960, p. 1493
Same Skeleton Products
Historical Records